شرح مبسّط
Gene editing in agriculture is further ahead than in medicine, because the regulatory bar is lower and the delivery problem is easier — you can edit a single plant cell and grow a whole plant from it. Several countries now treat an edited crop as equivalent to a conventionally bred one if the change contains no foreign DNA, which means no special approval process at all.
تعمق أكثر
Plant editing benefits from totipotency: an edited cell can regenerate a whole organism, so delivery is not the constraint it is in animals. Regulatory treatment diverges sharply. The United States exempts certain edited plants from biotechnology regulation where the modification could have been achieved by conventional breeding; Japan, Argentina, Brazil and others apply similar product-based frameworks. The European Union historically applied GMO rules following the 2018 Court of Justice ruling, with reform of the rules for new genomic techniques under negotiation.
Traditional breeding, GMO and gene editing
| Approach | What happens | Time | Foreign DNA? |
|---|---|---|---|
| Traditional breeding | Crossing plants and selecting offspring, shuffling thousands of genes blindly | Years to decades | No |
| Mutation breeding | Radiation or chemicals to create random mutations, then selection | Years | No |
| GMO (transgenic) | A gene from another organism inserted deliberately | Years | Yes |
| Gene editing | A targeted change to the plant's own DNA | Months to years | Usually not |
Mutation breeding — creating thousands of random, uncharacterised mutations with radiation — has been used since the 1950s and is generally unregulated, including in organic agriculture. That comparison is central to the argument that targeted single-letter editing is being held to a stricter standard than the alternatives.